The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...

The antibody-drug conjugate (ADC), marketed by ADC Therapeutics under the brand name Zynlonta, received accelerated approval ...

Study authors Susan D. Reed, MD, MPH, MS, and Erin Dwyer, MPH, both at the University of Washington School of Medicine, attribute some of these different challenges to underlying health disparities.

A prediction of 2025 by Doug Mirsky, Ph.D., vice president of healthcare delivery at Digital Medicine Society.

A prediction for this year by Shawn Gremminger, president and CEO of National Alliance of Healthcare Purchaser Coalitions.

Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...

Vold, M.D., Ph.D., discusses the current treatment landscape for progressive pulmonary fibrosis, highlighting nonpharmacological and pharmacological options to manage the disease.

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...